1. Cardiac effects of lanreotide, a slow release somatostatin analog, in acromegalic patients;Baldelli;Journal of Clinical Endocrinology and Metabolism,1999
2. An audit of outcome of treatment in acromegaly;Bates;Quarterly Journal of Medicine,1993
3. Epidemiology and long term survival in acromegaly;Bengtsson;Acta Medica Scandinavica,1988
4. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy;Colao;Journal of Clinical Endocrinology and Metabolism,2000a
5. Is the acromegalic cardiomyopathy reversible? Effect of 5 year normalization of growth hormone and insulin-like growth factor-I levels on cardiac performance;Colao;Journal of Clinical Endocrinology Metabolism,2001c